Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options (NASDAQ:CODX)
CDICDI(US:CODX) Seeking Alpha·2026-04-01 06:43

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

CDI-Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options (NASDAQ:CODX) - Reportify